Epprazole enteric-coated tablets are mainly indicated for the treatment of duodenal ulcers, mainly for adults with duodenal ulcers. There are contraindications and precautions for taking any medication: it is contraindicated for those who are allergic to epprazole and other benzimidazole compounds, and for those with hepatic or renal insufficiency. In addition, it should be noted that: this product can not be chewed or crushed, should be swallowed whole, epprazole inhibits gastric acid secretion, for general peptic ulcer and other diseases, should not be long-term large doses, before use should be excluded from the stomach and esophagus of malignant lesions, so as not to delay diagnosis due to symptomatic relief, is generally not recommended for pregnant women and lactating mothers, if lactating mothers must be used when the drug should be suspended breastfeeding, infants and young children are contraindicated, Gastric acid secretion ability and other physiological functions of elderly patients will be reduced, the use of drugs should be careful.